Technology Transfer Office

Our history

Institut Curie
Institut Curie's Technology Transfer Office was founded in 2003. It now has over 10 years of experience in the valorization and commercialization of Institut Curie's innovations.
Equipe valorisation Dossiers



  • 2002: Commercialization agreement signed with BTG International for medical device
  • 2003: Exclusive license with Oncodesign for prostate cancer PDX
  • 2005: Exclusive license with Asylum on Atomic Force Microscopy
  • 2008: Exclusive license with DNA therapeutics (acquired by ONXEO) for Dbait small molecule
  • 2014: Exclusive license with Abbott on Bladder cancer biomarker

Major industrial partnerships


More about us
Our missions

The mission of Institut Curie's Technology Transfer Office is to ensure that Institut Curie and partners' inventions…

TTO Team
Our team

Institut Curie's Technology Transfer Office is a team of 18 people dedicated to the detection, development, protection…

Equipe Signalisation, développement et tumeurs cérébrales
Our network

Institut Curie TTO is the body authorized to represent Institut Curie researchers and clinicians in all IP matters…

Comité TT
Our governance

In order to carry out its missions, Institut Curie's Technology Transfer Office has set up a multi-level structure of…